Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

SELARL PHARMACIE DE BONNEVEINE : revenue, balance sheet and financial ratios

SELARL PHARMACIE DE BONNEVEINE is a French company founded 15 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in MARSEILLE (13008), this company of category PME shows in 2020 a net income positive of 139 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SELARL PHARMACIE DE BONNEVEINE (SIREN 524800265)
Indicator 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C N/C
Net income 138 902 € -80 503 € -396 989 € 519 794 € -835 656 €
EBITDA N/C N/C N/C N/C N/C
Net margin N/C N/C N/C N/C N/C

Revenue and income statement

In 2020, SELARL PHARMACIE DE BONNEVEINE generates positive net income of 139 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

138 902 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at -1257%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches -6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

-1256.862%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

-6.352%

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

4.3%

Solvency indicators evolution
SELARL PHARMACIE DE BONNEVEINE

Sector positioning

Debt ratio
-1256.86 2020
2018
2019
2020
Q1: 33.2
Med: 96.78
Q3: 238.43
Excellent

In 2020, the debt ratio of SELARL PHARMACIE DE BONNE... (-1256.86) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
-6.35% 2020
2018
2019
2020
Q1: 23.59%
Med: 41.65%
Q3: 61.95%
Watch

In 2020, the financial autonomy of SELARL PHARMACIE DE BONNE... (-6.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 82.46. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

82.457

Liquidity indicators evolution
SELARL PHARMACIE DE BONNEVEINE

Sector positioning

Liquidity ratio
82.46 2020
2018
2019
2020
Q1: 133.12
Med: 181.89
Q3: 251.9
Watch

In 2020, the liquidity ratio of SELARL PHARMACIE DE BONNE... (82.46) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 70 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 893 days. Excellent situation: suppliers finance 823 days of the operating cycle (retail model).

Operating WCR (2020) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2020) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

70 j

Supplier credit (2020) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

893 j

Inventory turnover (2020) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SELARL PHARMACIE DE BONNEVEINE

Positioning of SELARL PHARMACIE DE BONNEVEINE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 180 transactions of similar company sales in 2020, the value of SELARL PHARMACIE DE BONNEVEINE is estimated at 1 963 054 € (range 1 308 937€ - 2 648 690€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2020
180 transactions
1308k€ 1963k€ 2648k€
1 963 054 € Range: 1 308 937€ - 2 648 690€
NAF 5 année 2020

Valuation method used

Net Income Multiple
138 902 € × 14.1x = 1 963 055 €
Range: 1 308 937€ - 2 648 690€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 180 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SELARL PHARMACIE DE BONNEVEINE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SELARL PHARMACIE DE BONNEVEINE

What is the revenue of SELARL PHARMACIE DE BONNEVEINE ?

The revenue of SELARL PHARMACIE DE BONNEVEINE is not publicly disclosed (confidential accounts filed with INPI).

Is SELARL PHARMACIE DE BONNEVEINE profitable?

Yes, SELARL PHARMACIE DE BONNEVEINE generated a net profit of 139 k€ in 2020.

Where is the headquarters of SELARL PHARMACIE DE BONNEVEINE ?

The headquarters of SELARL PHARMACIE DE BONNEVEINE is located in MARSEILLE (13008), in the department Bouches-du-Rhone.

Where to find the tax return of SELARL PHARMACIE DE BONNEVEINE ?

The tax return of SELARL PHARMACIE DE BONNEVEINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SELARL PHARMACIE DE BONNEVEINE operate?

SELARL PHARMACIE DE BONNEVEINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.